Patient-Induced Pluripotent Stem Cell–Derived Hepatostellate Organoids Establish a Basis for Liver Pathologies in Telomeropathies

• Published in: Cellular and molecular gastroenterology and hepatology Vol. 16; no. 3; pp. 451 - 472
• Main Authors: Choi, Young-Jun, Kim, Melissa S., Rhoades, Joshua H., Johnson, Nicolette M., Berry, Corbett T., Root, Sarah, Chen, Qijun, Tian, Yuhua, Fernandez, Rafael J., Cramer, Zvi, Adams-Tzivelekidis, Stephanie, Li, Ning, Johnson, F. Brad, Lengner, Christopher J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.2023; Elsevier
• Subjects: Cell Cycle Proteins - genetics; Cell Differentiation - genetics; DKC1; Dyskeratosis Congenita; Hepatocyte; Humans; Hyperplasia - pathology; Induced Pluripotent Stem Cells; iPS Cell; Liver - pathology; Liver Organoid; Nuclear Proteins; Organoid; Organoids - pathology; Original Research; Stellate Cell; Telomere; PFA; Telomere; scRNAseq; gRNA; BSA; 2D; Hepatocyte; HSC; TeSLA; PBS; eGFP; SSC; IL; Stellate Cell; iPS Cell; iPSC; qRT-PCR; Organoid; GSEA; ES; Dyskeratosis Congenita; PCA; TIF; 3D; HEP; DKC1; Liver Organoid; Dex; ALB; HB; DC
• ISSN: 2352-345X; 2352-345X
• DOI: 10.1016/j.jcmgh.2023.06.003

Dyskeratosis congenita (DC) is a telomere biology disorder caused primarily by mutations in the DKC1 gene. Patients with DC and related telomeropathies resulting from premature telomere dysfunction experience multiorgan failure. In the liver, DC patients present with nodular hyperplasia, steatosis, inflammation, and cirrhosis. However, the mechanism responsible for telomere dysfunction–induced liver disease remains unclear. We used isogenic human induced pluripotent stem cells (iPSCs) harboring a causal DC mutation in DKC1 or a CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/Cas9)–corrected control allele to model DC liver pathologies. We differentiated these iPSCs into hepatocytes (HEPs) or hepatic stellate cells (HSCs) followed by generation of genotype-admixed hepatostellate organoids. Single-cell transcriptomics were applied to hepatostellate organoids to understand cell type–specific genotype-phenotype relationships. Directed differentiation of iPSCs into HEPs and stellate cells and subsequent hepatostellate organoid formation revealed a dominant phenotype in the parenchyma, with DC HEPs becoming hyperplastic and also eliciting a pathogenic hyperplastic, proinflammatory response in stellate cells independent of stellate cell genotype. Pathogenic phenotypes in DKC1-mutant HEPs and hepatostellate organoids could be rescued via suppression of serine/threonine kinase AKT (protein kinase B) activity, a central regulator of MYC-driven hyperplasia downstream of DKC1 mutation. Isogenic iPSC-derived admixed hepatostellate organoids offer insight into the liver pathologies in telomeropathies and provide a framework for evaluating emerging therapies. [Display omitted]